Global Gene Therapy For Neurodegenerative Diseases Market Research Report 2026(Status and Outlook)
The global Gene Therapy For Neurodegenerative Diseases market size was estimated at USD 4205.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 18.65% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapy For Neurodegenerative Diseases market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapy For Neurodegenerative Diseases market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapy For Neurodegenerative Diseases market.
Global Gene Therapy For Neurodegenerative Diseases Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Voyager Therapeutics
Uniqure N.V.
Axovant Gene Therapies
Novartis Ag
Amicus Therapeutics
Regenxbio Inc.
Sarepta Therapeutics
Gensight Biologics
Krystal Biotech
Avexis
Market Segmentation (by Type)
Gene Replacement Therapy
Gene Silencing Therapy
Gene Editing Therapy
Enzyme Replacement Therapy
Market Segmentation (by Application)
Hospitals and Clinics
Research Institutions
Biotechnology Companies
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy For Neurodegenerative Diseases Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy For Neurodegenerative Diseases, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Gene Therapy For Neurodegenerative Diseases market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapy For Neurodegenerative Diseases market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapy For Neurodegenerative Diseases market.
Global Gene Therapy For Neurodegenerative Diseases Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Voyager Therapeutics
Uniqure N.V.
Axovant Gene Therapies
Novartis Ag
Amicus Therapeutics
Regenxbio Inc.
Sarepta Therapeutics
Gensight Biologics
Krystal Biotech
Avexis
Market Segmentation (by Type)
Gene Replacement Therapy
Gene Silencing Therapy
Gene Editing Therapy
Enzyme Replacement Therapy
Market Segmentation (by Application)
Hospitals and Clinics
Research Institutions
Biotechnology Companies
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gene Therapy For Neurodegenerative Diseases Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy For Neurodegenerative Diseases Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy For Neurodegenerative Diseases, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Therapy For Neurodegenerative Diseases
1.2 Key Market Segments
1.2.1 Gene Therapy For Neurodegenerative Diseases Segment by Type
1.2.2 Gene Therapy For Neurodegenerative Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Therapy For Neurodegenerative Diseases Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy For Neurodegenerative Diseases Product Life Cycle
3.3 Global Gene Therapy For Neurodegenerative Diseases Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy For Neurodegenerative Diseases Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy For Neurodegenerative Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy For Neurodegenerative Diseases Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy For Neurodegenerative Diseases Market Competitive Situation and Trends
3.8.1 Gene Therapy For Neurodegenerative Diseases Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy For Neurodegenerative Diseases Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY FOR NEURODEGENERATIVE DISEASES INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy For Neurodegenerative Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy For Neurodegenerative Diseases Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy For Neurodegenerative Diseases Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy For Neurodegenerative Diseases Market Size by Type (2020-2025)
6.4 Global Gene Therapy For Neurodegenerative Diseases Price by Type (2020-2025)
7 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy For Neurodegenerative Diseases Market Sales by Application (2020-2025)
7.3 Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy For Neurodegenerative Diseases Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET SALES BY REGION
8.1 Global Gene Therapy For Neurodegenerative Diseases Sales by Region
8.1.1 Global Gene Therapy For Neurodegenerative Diseases Sales by Region
8.1.2 Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region
8.2 Global Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.2.1 Global Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.2.2 Global Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.3 North America
8.3.1 North America Gene Therapy For Neurodegenerative Diseases Sales by Country
8.3.2 North America Gene Therapy For Neurodegenerative Diseases Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy For Neurodegenerative Diseases Sales by Country
8.4.2 Europe Gene Therapy For Neurodegenerative Diseases Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales by Region
8.5.2 Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy For Neurodegenerative Diseases Sales by Country
8.6.2 South America Gene Therapy For Neurodegenerative Diseases Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales by Region
8.7.2 Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy For Neurodegenerative Diseases by Region(2020-2025)
9.2 Global Gene Therapy For Neurodegenerative Diseases Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy For Neurodegenerative Diseases Production
9.4.1 North America Gene Therapy For Neurodegenerative Diseases Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy For Neurodegenerative Diseases Production
9.5.1 Europe Gene Therapy For Neurodegenerative Diseases Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy For Neurodegenerative Diseases Production (2020-2025)
9.6.1 Japan Gene Therapy For Neurodegenerative Diseases Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy For Neurodegenerative Diseases Production (2020-2025)
9.7.1 China Gene Therapy For Neurodegenerative Diseases Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Voyager Therapeutics
10.1.1 Voyager Therapeutics Basic Information
10.1.2 Voyager Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
10.1.3 Voyager Therapeutics Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.1.4 Voyager Therapeutics Business Overview
10.1.5 Voyager Therapeutics SWOT Analysis
10.1.6 Voyager Therapeutics Recent Developments
10.2 Uniqure N.V.
10.2.1 Uniqure N.V. Basic Information
10.2.2 Uniqure N.V. Gene Therapy For Neurodegenerative Diseases Product Overview
10.2.3 Uniqure N.V. Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.2.4 Uniqure N.V. Business Overview
10.2.5 Uniqure N.V. SWOT Analysis
10.2.6 Uniqure N.V. Recent Developments
10.3 Axovant Gene Therapies
10.3.1 Axovant Gene Therapies Basic Information
10.3.2 Axovant Gene Therapies Gene Therapy For Neurodegenerative Diseases Product Overview
10.3.3 Axovant Gene Therapies Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.3.4 Axovant Gene Therapies Business Overview
10.3.5 Axovant Gene Therapies SWOT Analysis
10.3.6 Axovant Gene Therapies Recent Developments
10.4 Novartis Ag
10.4.1 Novartis Ag Basic Information
10.4.2 Novartis Ag Gene Therapy For Neurodegenerative Diseases Product Overview
10.4.3 Novartis Ag Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.4.4 Novartis Ag Business Overview
10.4.5 Novartis Ag Recent Developments
10.5 Amicus Therapeutics
10.5.1 Amicus Therapeutics Basic Information
10.5.2 Amicus Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
10.5.3 Amicus Therapeutics Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.5.4 Amicus Therapeutics Business Overview
10.5.5 Amicus Therapeutics Recent Developments
10.6 Regenxbio Inc.
10.6.1 Regenxbio Inc. Basic Information
10.6.2 Regenxbio Inc. Gene Therapy For Neurodegenerative Diseases Product Overview
10.6.3 Regenxbio Inc. Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.6.4 Regenxbio Inc. Business Overview
10.6.5 Regenxbio Inc. Recent Developments
10.7 Sarepta Therapeutics
10.7.1 Sarepta Therapeutics Basic Information
10.7.2 Sarepta Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
10.7.3 Sarepta Therapeutics Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.7.4 Sarepta Therapeutics Business Overview
10.7.5 Sarepta Therapeutics Recent Developments
10.8 Gensight Biologics
10.8.1 Gensight Biologics Basic Information
10.8.2 Gensight Biologics Gene Therapy For Neurodegenerative Diseases Product Overview
10.8.3 Gensight Biologics Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.8.4 Gensight Biologics Business Overview
10.8.5 Gensight Biologics Recent Developments
10.9 Krystal Biotech
10.9.1 Krystal Biotech Basic Information
10.9.2 Krystal Biotech Gene Therapy For Neurodegenerative Diseases Product Overview
10.9.3 Krystal Biotech Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.9.4 Krystal Biotech Business Overview
10.9.5 Krystal Biotech Recent Developments
10.10 Avexis
10.10.1 Avexis Basic Information
10.10.2 Avexis Gene Therapy For Neurodegenerative Diseases Product Overview
10.10.3 Avexis Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.10.4 Avexis Business Overview
10.10.5 Avexis Recent Developments
11 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET FORECAST BY REGION
11.1 Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast
11.2 Global Gene Therapy For Neurodegenerative Diseases Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Region
11.2.4 South America Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy For Neurodegenerative Diseases by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Therapy For Neurodegenerative Diseases Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Therapy For Neurodegenerative Diseases by Type (2026-2035)
12.1.2 Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Therapy For Neurodegenerative Diseases by Type (2026-2035)
12.2 Global Gene Therapy For Neurodegenerative Diseases Market Forecast by Application (2026-2035)
12.2.1 Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Therapy For Neurodegenerative Diseases
1.2 Key Market Segments
1.2.1 Gene Therapy For Neurodegenerative Diseases Segment by Type
1.2.2 Gene Therapy For Neurodegenerative Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Therapy For Neurodegenerative Diseases Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy For Neurodegenerative Diseases Product Life Cycle
3.3 Global Gene Therapy For Neurodegenerative Diseases Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy For Neurodegenerative Diseases Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy For Neurodegenerative Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy For Neurodegenerative Diseases Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy For Neurodegenerative Diseases Market Competitive Situation and Trends
3.8.1 Gene Therapy For Neurodegenerative Diseases Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy For Neurodegenerative Diseases Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY FOR NEURODEGENERATIVE DISEASES INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy For Neurodegenerative Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy For Neurodegenerative Diseases Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy For Neurodegenerative Diseases Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy For Neurodegenerative Diseases Market Size by Type (2020-2025)
6.4 Global Gene Therapy For Neurodegenerative Diseases Price by Type (2020-2025)
7 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy For Neurodegenerative Diseases Market Sales by Application (2020-2025)
7.3 Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy For Neurodegenerative Diseases Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET SALES BY REGION
8.1 Global Gene Therapy For Neurodegenerative Diseases Sales by Region
8.1.1 Global Gene Therapy For Neurodegenerative Diseases Sales by Region
8.1.2 Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region
8.2 Global Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.2.1 Global Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.2.2 Global Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.3 North America
8.3.1 North America Gene Therapy For Neurodegenerative Diseases Sales by Country
8.3.2 North America Gene Therapy For Neurodegenerative Diseases Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy For Neurodegenerative Diseases Sales by Country
8.4.2 Europe Gene Therapy For Neurodegenerative Diseases Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales by Region
8.5.2 Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy For Neurodegenerative Diseases Sales by Country
8.6.2 South America Gene Therapy For Neurodegenerative Diseases Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales by Region
8.7.2 Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy For Neurodegenerative Diseases by Region(2020-2025)
9.2 Global Gene Therapy For Neurodegenerative Diseases Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy For Neurodegenerative Diseases Production
9.4.1 North America Gene Therapy For Neurodegenerative Diseases Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy For Neurodegenerative Diseases Production
9.5.1 Europe Gene Therapy For Neurodegenerative Diseases Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy For Neurodegenerative Diseases Production (2020-2025)
9.6.1 Japan Gene Therapy For Neurodegenerative Diseases Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy For Neurodegenerative Diseases Production (2020-2025)
9.7.1 China Gene Therapy For Neurodegenerative Diseases Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy For Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Voyager Therapeutics
10.1.1 Voyager Therapeutics Basic Information
10.1.2 Voyager Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
10.1.3 Voyager Therapeutics Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.1.4 Voyager Therapeutics Business Overview
10.1.5 Voyager Therapeutics SWOT Analysis
10.1.6 Voyager Therapeutics Recent Developments
10.2 Uniqure N.V.
10.2.1 Uniqure N.V. Basic Information
10.2.2 Uniqure N.V. Gene Therapy For Neurodegenerative Diseases Product Overview
10.2.3 Uniqure N.V. Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.2.4 Uniqure N.V. Business Overview
10.2.5 Uniqure N.V. SWOT Analysis
10.2.6 Uniqure N.V. Recent Developments
10.3 Axovant Gene Therapies
10.3.1 Axovant Gene Therapies Basic Information
10.3.2 Axovant Gene Therapies Gene Therapy For Neurodegenerative Diseases Product Overview
10.3.3 Axovant Gene Therapies Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.3.4 Axovant Gene Therapies Business Overview
10.3.5 Axovant Gene Therapies SWOT Analysis
10.3.6 Axovant Gene Therapies Recent Developments
10.4 Novartis Ag
10.4.1 Novartis Ag Basic Information
10.4.2 Novartis Ag Gene Therapy For Neurodegenerative Diseases Product Overview
10.4.3 Novartis Ag Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.4.4 Novartis Ag Business Overview
10.4.5 Novartis Ag Recent Developments
10.5 Amicus Therapeutics
10.5.1 Amicus Therapeutics Basic Information
10.5.2 Amicus Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
10.5.3 Amicus Therapeutics Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.5.4 Amicus Therapeutics Business Overview
10.5.5 Amicus Therapeutics Recent Developments
10.6 Regenxbio Inc.
10.6.1 Regenxbio Inc. Basic Information
10.6.2 Regenxbio Inc. Gene Therapy For Neurodegenerative Diseases Product Overview
10.6.3 Regenxbio Inc. Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.6.4 Regenxbio Inc. Business Overview
10.6.5 Regenxbio Inc. Recent Developments
10.7 Sarepta Therapeutics
10.7.1 Sarepta Therapeutics Basic Information
10.7.2 Sarepta Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
10.7.3 Sarepta Therapeutics Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.7.4 Sarepta Therapeutics Business Overview
10.7.5 Sarepta Therapeutics Recent Developments
10.8 Gensight Biologics
10.8.1 Gensight Biologics Basic Information
10.8.2 Gensight Biologics Gene Therapy For Neurodegenerative Diseases Product Overview
10.8.3 Gensight Biologics Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.8.4 Gensight Biologics Business Overview
10.8.5 Gensight Biologics Recent Developments
10.9 Krystal Biotech
10.9.1 Krystal Biotech Basic Information
10.9.2 Krystal Biotech Gene Therapy For Neurodegenerative Diseases Product Overview
10.9.3 Krystal Biotech Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.9.4 Krystal Biotech Business Overview
10.9.5 Krystal Biotech Recent Developments
10.10 Avexis
10.10.1 Avexis Basic Information
10.10.2 Avexis Gene Therapy For Neurodegenerative Diseases Product Overview
10.10.3 Avexis Gene Therapy For Neurodegenerative Diseases Product Market Performance
10.10.4 Avexis Business Overview
10.10.5 Avexis Recent Developments
11 GENE THERAPY FOR NEURODEGENERATIVE DISEASES MARKET FORECAST BY REGION
11.1 Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast
11.2 Global Gene Therapy For Neurodegenerative Diseases Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Region
11.2.4 South America Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy For Neurodegenerative Diseases by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Therapy For Neurodegenerative Diseases Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Therapy For Neurodegenerative Diseases by Type (2026-2035)
12.1.2 Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Therapy For Neurodegenerative Diseases by Type (2026-2035)
12.2 Global Gene Therapy For Neurodegenerative Diseases Market Forecast by Application (2026-2035)
12.2.1 Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Therapy For Neurodegenerative Diseases Market Size by Type (M USD)
Table 4. Global Gene Therapy For Neurodegenerative Diseases Market Size by Application
Table 5. Gene Therapy For Neurodegenerative Diseases Market Size Comparison by Region (M USD)
Table 6. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Therapy For Neurodegenerative Diseases Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Therapy For Neurodegenerative Diseases Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Neurodegenerative Diseases as of 2025)
Table 11. Global Market Gene Therapy For Neurodegenerative Diseases Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gene Therapy For Neurodegenerative Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy For Neurodegenerative Diseases Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Therapy For Neurodegenerative Diseases Sales by Type (K Units)
Table 27. Global Gene Therapy For Neurodegenerative Diseases Market Size by Type (M USD)
Table 28. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) by Type (2020-2025)
Table 29. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Type (2020-2025)
Table 30. Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Therapy For Neurodegenerative Diseases Market Share by Type (2020-2025)
Table 32. Global Gene Therapy For Neurodegenerative Diseases Price (USD/Unit) by Type (2020-2025)
Table 33. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) by Application
Table 34. Global Gene Therapy For Neurodegenerative Diseases Market Size by Application
Table 35. Global Gene Therapy For Neurodegenerative Diseases Sales by Application (2020-2025) & (K Units)
Table 36. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Application (2020-2025)
Table 37. Global Gene Therapy For Neurodegenerative Diseases Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Therapy For Neurodegenerative Diseases Market Share by Application (2020-2025)
Table 39. Global Gene Therapy For Neurodegenerative Diseases Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Therapy For Neurodegenerative Diseases Sales by Region (2020-2025) & (K Units)
Table 41. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region (2020-2025)
Table 42. Global Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025)
Table 44. North America Gene Therapy For Neurodegenerative Diseases Sales by Country (2020-2025) & (K Units)
Table 45. North America Gene Therapy For Neurodegenerative Diseases Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Therapy For Neurodegenerative Diseases Sales by Country (2020-2025) & (K Units)
Table 47. Europe Gene Therapy For Neurodegenerative Diseases Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Therapy For Neurodegenerative Diseases Sales by Country (2020-2025) & (K Units)
Table 51. South America Gene Therapy For Neurodegenerative Diseases Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Therapy For Neurodegenerative Diseases Production (K Units) by Region(2020-2025)
Table 55. Global Gene Therapy For Neurodegenerative Diseases Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Therapy For Neurodegenerative Diseases Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Voyager Therapeutics Basic Information
Table 63. Voyager Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
Table 64. Voyager Therapeutics Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Voyager Therapeutics Business Overview
Table 66. Voyager Therapeutics SWOT Analysis
Table 67. Voyager Therapeutics Recent Developments
Table 68. Uniqure N.V. Basic Information
Table 69. Uniqure N.V. Gene Therapy For Neurodegenerative Diseases Product Overview
Table 70. Uniqure N.V. Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Uniqure N.V. Business Overview
Table 72. Uniqure N.V. SWOT Analysis
Table 73. Uniqure N.V. Recent Developments
Table 74. Axovant Gene Therapies Basic Information
Table 75. Axovant Gene Therapies Gene Therapy For Neurodegenerative Diseases Product Overview
Table 76. Axovant Gene Therapies Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Axovant Gene Therapies Business Overview
Table 78. Axovant Gene Therapies SWOT Analysis
Table 79. Axovant Gene Therapies Recent Developments
Table 80. Novartis Ag Basic Information
Table 81. Novartis Ag Gene Therapy For Neurodegenerative Diseases Product Overview
Table 82. Novartis Ag Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Ag Business Overview
Table 84. Novartis Ag Recent Developments
Table 85. Amicus Therapeutics Basic Information
Table 86. Amicus Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
Table 87. Amicus Therapeutics Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Amicus Therapeutics Business Overview
Table 89. Amicus Therapeutics Recent Developments
Table 90. Regenxbio Inc. Basic Information
Table 91. Regenxbio Inc. Gene Therapy For Neurodegenerative Diseases Product Overview
Table 92. Regenxbio Inc. Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Regenxbio Inc. Business Overview
Table 94. Regenxbio Inc. Recent Developments
Table 95. Sarepta Therapeutics Basic Information
Table 96. Sarepta Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
Table 97. Sarepta Therapeutics Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sarepta Therapeutics Business Overview
Table 99. Sarepta Therapeutics Recent Developments
Table 100. Gensight Biologics Basic Information
Table 101. Gensight Biologics Gene Therapy For Neurodegenerative Diseases Product Overview
Table 102. Gensight Biologics Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Gensight Biologics Business Overview
Table 104. Gensight Biologics Recent Developments
Table 105. Krystal Biotech Basic Information
Table 106. Krystal Biotech Gene Therapy For Neurodegenerative Diseases Product Overview
Table 107. Krystal Biotech Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Krystal Biotech Business Overview
Table 109. Krystal Biotech Recent Developments
Table 110. Avexis Basic Information
Table 111. Avexis Gene Therapy For Neurodegenerative Diseases Product Overview
Table 112. Avexis Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Avexis Business Overview
Table 114. Avexis Recent Developments
Table 115. Global Gene Therapy For Neurodegenerative Diseases Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Gene Therapy For Neurodegenerative Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Gene Therapy For Neurodegenerative Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Gene Therapy For Neurodegenerative Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Gene Therapy For Neurodegenerative Diseases Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Gene Therapy For Neurodegenerative Diseases Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Therapy For Neurodegenerative Diseases Market Size by Type (M USD)
Table 4. Global Gene Therapy For Neurodegenerative Diseases Market Size by Application
Table 5. Gene Therapy For Neurodegenerative Diseases Market Size Comparison by Region (M USD)
Table 6. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Therapy For Neurodegenerative Diseases Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Therapy For Neurodegenerative Diseases Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Neurodegenerative Diseases as of 2025)
Table 11. Global Market Gene Therapy For Neurodegenerative Diseases Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gene Therapy For Neurodegenerative Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy For Neurodegenerative Diseases Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Therapy For Neurodegenerative Diseases Sales by Type (K Units)
Table 27. Global Gene Therapy For Neurodegenerative Diseases Market Size by Type (M USD)
Table 28. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) by Type (2020-2025)
Table 29. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Type (2020-2025)
Table 30. Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Therapy For Neurodegenerative Diseases Market Share by Type (2020-2025)
Table 32. Global Gene Therapy For Neurodegenerative Diseases Price (USD/Unit) by Type (2020-2025)
Table 33. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) by Application
Table 34. Global Gene Therapy For Neurodegenerative Diseases Market Size by Application
Table 35. Global Gene Therapy For Neurodegenerative Diseases Sales by Application (2020-2025) & (K Units)
Table 36. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Application (2020-2025)
Table 37. Global Gene Therapy For Neurodegenerative Diseases Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Therapy For Neurodegenerative Diseases Market Share by Application (2020-2025)
Table 39. Global Gene Therapy For Neurodegenerative Diseases Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Therapy For Neurodegenerative Diseases Sales by Region (2020-2025) & (K Units)
Table 41. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region (2020-2025)
Table 42. Global Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025)
Table 44. North America Gene Therapy For Neurodegenerative Diseases Sales by Country (2020-2025) & (K Units)
Table 45. North America Gene Therapy For Neurodegenerative Diseases Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Therapy For Neurodegenerative Diseases Sales by Country (2020-2025) & (K Units)
Table 47. Europe Gene Therapy For Neurodegenerative Diseases Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Therapy For Neurodegenerative Diseases Sales by Country (2020-2025) & (K Units)
Table 51. South America Gene Therapy For Neurodegenerative Diseases Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Therapy For Neurodegenerative Diseases Production (K Units) by Region(2020-2025)
Table 55. Global Gene Therapy For Neurodegenerative Diseases Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Therapy For Neurodegenerative Diseases Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Gene Therapy For Neurodegenerative Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Voyager Therapeutics Basic Information
Table 63. Voyager Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
Table 64. Voyager Therapeutics Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Voyager Therapeutics Business Overview
Table 66. Voyager Therapeutics SWOT Analysis
Table 67. Voyager Therapeutics Recent Developments
Table 68. Uniqure N.V. Basic Information
Table 69. Uniqure N.V. Gene Therapy For Neurodegenerative Diseases Product Overview
Table 70. Uniqure N.V. Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Uniqure N.V. Business Overview
Table 72. Uniqure N.V. SWOT Analysis
Table 73. Uniqure N.V. Recent Developments
Table 74. Axovant Gene Therapies Basic Information
Table 75. Axovant Gene Therapies Gene Therapy For Neurodegenerative Diseases Product Overview
Table 76. Axovant Gene Therapies Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Axovant Gene Therapies Business Overview
Table 78. Axovant Gene Therapies SWOT Analysis
Table 79. Axovant Gene Therapies Recent Developments
Table 80. Novartis Ag Basic Information
Table 81. Novartis Ag Gene Therapy For Neurodegenerative Diseases Product Overview
Table 82. Novartis Ag Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Ag Business Overview
Table 84. Novartis Ag Recent Developments
Table 85. Amicus Therapeutics Basic Information
Table 86. Amicus Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
Table 87. Amicus Therapeutics Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Amicus Therapeutics Business Overview
Table 89. Amicus Therapeutics Recent Developments
Table 90. Regenxbio Inc. Basic Information
Table 91. Regenxbio Inc. Gene Therapy For Neurodegenerative Diseases Product Overview
Table 92. Regenxbio Inc. Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Regenxbio Inc. Business Overview
Table 94. Regenxbio Inc. Recent Developments
Table 95. Sarepta Therapeutics Basic Information
Table 96. Sarepta Therapeutics Gene Therapy For Neurodegenerative Diseases Product Overview
Table 97. Sarepta Therapeutics Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sarepta Therapeutics Business Overview
Table 99. Sarepta Therapeutics Recent Developments
Table 100. Gensight Biologics Basic Information
Table 101. Gensight Biologics Gene Therapy For Neurodegenerative Diseases Product Overview
Table 102. Gensight Biologics Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Gensight Biologics Business Overview
Table 104. Gensight Biologics Recent Developments
Table 105. Krystal Biotech Basic Information
Table 106. Krystal Biotech Gene Therapy For Neurodegenerative Diseases Product Overview
Table 107. Krystal Biotech Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Krystal Biotech Business Overview
Table 109. Krystal Biotech Recent Developments
Table 110. Avexis Basic Information
Table 111. Avexis Gene Therapy For Neurodegenerative Diseases Product Overview
Table 112. Avexis Gene Therapy For Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Avexis Business Overview
Table 114. Avexis Recent Developments
Table 115. Global Gene Therapy For Neurodegenerative Diseases Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Gene Therapy For Neurodegenerative Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Gene Therapy For Neurodegenerative Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Gene Therapy For Neurodegenerative Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Gene Therapy For Neurodegenerative Diseases Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Gene Therapy For Neurodegenerative Diseases Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene Therapy For Neurodegenerative Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD), 2025-2035
Figure 5. Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) (2020-2035)
Figure 6. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy For Neurodegenerative Diseases Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy For Neurodegenerative Diseases Product Life Cycle
Figure 13. Gene Therapy For Neurodegenerative Diseases Sales Share by Manufacturers in 2025
Figure 14. Global Gene Therapy For Neurodegenerative Diseases Revenue Share by Manufacturers in 2025
Figure 15. Gene Therapy For Neurodegenerative Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Therapy For Neurodegenerative Diseases Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy For Neurodegenerative Diseases Revenue in 2025
Figure 18. Industry Chain Map of Gene Therapy For Neurodegenerative Diseases
Figure 19. Global Gene Therapy For Neurodegenerative Diseases Market PEST Analysis
Figure 20. Global Gene Therapy For Neurodegenerative Diseases Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy For Neurodegenerative Diseases Market Share by Type
Figure 27. Sales Market Share of Gene Therapy For Neurodegenerative Diseases by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy For Neurodegenerative Diseases by Type in 2025
Figure 29. Market Share of Gene Therapy For Neurodegenerative Diseases by Type (2020-2025)
Figure 30. Market Share of Gene Therapy For Neurodegenerative Diseases by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy For Neurodegenerative Diseases Market Share by Application
Figure 33. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Application in 2025
Figure 35. Global Gene Therapy For Neurodegenerative Diseases Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy For Neurodegenerative Diseases Market Share by Application in 2025
Figure 37. Global Gene Therapy For Neurodegenerative Diseases Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025)
Figure 40. North America Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy For Neurodegenerative Diseases Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy For Neurodegenerative Diseases Market Size by Country in 2024
Figure 45. U.S. Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy For Neurodegenerative Diseases Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy For Neurodegenerative Diseases Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy For Neurodegenerative Diseases Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy For Neurodegenerative Diseases Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy For Neurodegenerative Diseases Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy For Neurodegenerative Diseases Market Size by Country in 2024
Figure 55. Germany Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size by Region in 2024
Figure 68. China Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy For Neurodegenerative Diseases Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy For Neurodegenerative Diseases Market Size by Country in 2024
Figure 82. Brazil Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy For Neurodegenerative Diseases Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy For Neurodegenerative Diseases Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy For Neurodegenerative Diseases Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy For Neurodegenerative Diseases Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy For Neurodegenerative Diseases Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy For Neurodegenerative Diseases Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Therapy For Neurodegenerative Diseases Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Therapy For Neurodegenerative Diseases Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Therapy For Neurodegenerative Diseases Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Gene Therapy For Neurodegenerative Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD), 2025-2035
Figure 5. Global Gene Therapy For Neurodegenerative Diseases Market Size (M USD) (2020-2035)
Figure 6. Global Gene Therapy For Neurodegenerative Diseases Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy For Neurodegenerative Diseases Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy For Neurodegenerative Diseases Product Life Cycle
Figure 13. Gene Therapy For Neurodegenerative Diseases Sales Share by Manufacturers in 2025
Figure 14. Global Gene Therapy For Neurodegenerative Diseases Revenue Share by Manufacturers in 2025
Figure 15. Gene Therapy For Neurodegenerative Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Therapy For Neurodegenerative Diseases Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy For Neurodegenerative Diseases Revenue in 2025
Figure 18. Industry Chain Map of Gene Therapy For Neurodegenerative Diseases
Figure 19. Global Gene Therapy For Neurodegenerative Diseases Market PEST Analysis
Figure 20. Global Gene Therapy For Neurodegenerative Diseases Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy For Neurodegenerative Diseases Market Share by Type
Figure 27. Sales Market Share of Gene Therapy For Neurodegenerative Diseases by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy For Neurodegenerative Diseases by Type in 2025
Figure 29. Market Share of Gene Therapy For Neurodegenerative Diseases by Type (2020-2025)
Figure 30. Market Share of Gene Therapy For Neurodegenerative Diseases by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy For Neurodegenerative Diseases Market Share by Application
Figure 33. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Application in 2025
Figure 35. Global Gene Therapy For Neurodegenerative Diseases Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy For Neurodegenerative Diseases Market Share by Application in 2025
Figure 37. Global Gene Therapy For Neurodegenerative Diseases Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy For Neurodegenerative Diseases Market Size by Region (2020-2025)
Figure 40. North America Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy For Neurodegenerative Diseases Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy For Neurodegenerative Diseases Market Size by Country in 2024
Figure 45. U.S. Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy For Neurodegenerative Diseases Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy For Neurodegenerative Diseases Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy For Neurodegenerative Diseases Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy For Neurodegenerative Diseases Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy For Neurodegenerative Diseases Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy For Neurodegenerative Diseases Market Size by Country in 2024
Figure 55. Germany Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy For Neurodegenerative Diseases Market Size by Region in 2024
Figure 68. China Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy For Neurodegenerative Diseases Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy For Neurodegenerative Diseases Market Size by Country in 2024
Figure 82. Brazil Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy For Neurodegenerative Diseases Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy For Neurodegenerative Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy For Neurodegenerative Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy For Neurodegenerative Diseases Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy For Neurodegenerative Diseases Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy For Neurodegenerative Diseases Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy For Neurodegenerative Diseases Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy For Neurodegenerative Diseases Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy For Neurodegenerative Diseases Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Gene Therapy For Neurodegenerative Diseases Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Therapy For Neurodegenerative Diseases Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Therapy For Neurodegenerative Diseases Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Therapy For Neurodegenerative Diseases Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Therapy For Neurodegenerative Diseases Market Share Forecast by Application (2026-2035)
